FindTrial
Sign In

Pathophysiology of Parkinson's disease and related disorders using THK5351 PET

Pathophysiology of Parkinson's disease and related disorders using THK5351 PET - Pathophysiology of Parkinson's disease and related disorders using THK5351 PET

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057139
Enrollment
30
Registered
2025-02-26
Start date
2023-02-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

THK5351 administered intravenously

Sponsors

Nagoya City Rehabilitation Agency
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are suspected of having Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, or other Parkinson's disease-related diseases among those who visit the Nagoya City Rehabilitation Center Hospital will be selected, and those who agree and consent to PET imaging for research purposes will be included.

Exclusion criteria

Exclusion criteria: Patients having history of seizure, alcoholism, or any kind of drug dependency. Patients recognized to be inappropriate by anyone of attending physicians or study staffs.

Design outcomes

Primary

MeasureTime frame
SUVR—

Countries

Japan

Contacts

Public ContactYoshihiko Horimoto

Nagoya City Rehabilitation Agency Department of Neurology

holly@nagoya-rehab.or.jp052-835-3811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026